Case Report: Adoptive T-Cell Tx Shows Promise in Glioblastoma
December 29, 2016 (HealthDay News) Tumors regressed after intracranial infusions of T cells engineered to target tumor-associated antigen Treatment with autologous chimeric antigen receptor (CAR)-engineered T cells targeting the tumor-associated …
Case Report: Adoptive T-Cell Tx Shows Promise in Glioblastoma Read More